# Optimizing Hydroxyurea Therapy in Children With SCA In Malaria Endemic Areas

> **NCT03128515** · PHASE3 · COMPLETED · sponsor: **Indiana University** · enrollment: 187 (actual)

## Conditions studied

- Sickle Cell Anemia
- Sickle Cell Disease
- Malaria

## Interventions

- **DRUG:** Hydroxyurea

## Key facts

- **NCT ID:** NCT03128515
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-26
- **Primary completion:** 2019-04-07
- **Final completion:** 2020-01-28
- **Target enrollment:** 187 (ACTUAL)
- **Last updated:** 2020-02-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03128515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03128515, "Optimizing Hydroxyurea Therapy in Children With SCA In Malaria Endemic Areas". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03128515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*